- Home
- TR vs SUPN Comparison
TR vs SUPN Comparison
Compare TR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- SUPN
- Stock Information
- Founded
- TR 1896
- SUPN 2005
- Country
- TR United States
- SUPN United States
- Employees
- TR N/A
- SUPN N/A
- Industry
- TR Specialty Foods
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- SUPN Health Care
- Exchange
- TR Nasdaq
- SUPN Nasdaq
- Market Cap
- TR 2.9B
- SUPN 2.6B
- IPO Year
- TR N/A
- SUPN 2012
- Fundamental
- Price
- TR $37.10
- SUPN $56.29
- Analyst Decision
- TR
- SUPN Strong Buy
- Analyst Count
- TR 0
- SUPN 4
- Target Price
- TR N/A
- SUPN $63.25
- AVG Volume (30 Days)
- TR 202.6K
- SUPN 808.1K
- Earning Date
- TR 10-23-2025
- SUPN 11-04-2025
- Dividend Yield
- TR 0.97%
- SUPN N/A
- EPS Growth
- TR N/A
- SUPN 1411.53
- EPS
- TR 1.24
- SUPN 1.14
- Revenue
- TR $722,849,000.00
- SUPN $665,125,000.00
- Revenue This Year
- TR N/A
- SUPN $7.31
- Revenue Next Year
- TR N/A
- SUPN $21.87
- P/E Ratio
- TR $28.38
- SUPN $48.66
- Revenue Growth
- TR N/A
- SUPN 5.55
- 52 Week Low
- TR $28.67
- SUPN $29.16
- 52 Week High
- TR $44.27
- SUPN $57.65
- Technical
- Relative Strength Index (RSI)
- TR 38.92
- SUPN 75.83
- Support Level
- TR $34.44
- SUPN $54.21
- Resistance Level
- TR $36.56
- SUPN $57.65
- Average True Range (ATR)
- TR 1.61
- SUPN 1.91
- MACD
- TR -0.51
- SUPN 0.36
- Stochastic Oscillator
- TR 27.56
- SUPN 87.79
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.